Eric Venker, President & Immunovant CEO: Roivant Sciences ROIV Planned sale · Filed 25/09/23

Trade details

Type: Planned sale notice
Stock: Roivant Sciences ROIV
Person: Eric VenkerPresident & Immunovant CEO
Planned sale date: 25/09/23
Filed: 25/09/23

More to sell after $12.5M in 3 months

Roivant Sciences trades, last 26 weeks

What else happened in Roivant Sciences around then

Filed or reported within 30 days of the trade day · 25/08/24~25/10/23

Eric Venker's recent trades

Eric VenkerPresident & Immunovant CEO
Planned sale10b5-1 planRoivant Sciences
Planned sale10b5-1 plan
Roivant Sciences
ROIV
$7.3M
200,000 sh
$7.3M
Filed 09/30
Traded 09/30
Eric VenkerPresident & Immunovant CEO
Planned sale10b5-1 planRoivant Sciences
Planned sale10b5-1 plan
Roivant Sciences
ROIV
$7.1M
200,000 sh
$7.1M
Filed 08/28
Traded 08/28
Eric VenkerPresident & Immunovant CEO
Planned sale10b5-1 planRoivant Sciences
Planned sale10b5-1 plan
Roivant Sciences
ROIV
$7M
200,000 sh
$7M
Filed 07/27
Traded 07/27
Eric VenkerPresident & Immunovant CEO
Sell10b5-1 planRoivant Sciences
Sell10b5-1 plan
Roivant Sciences
ROIV
$5.1M
153,766 sh
$5.1M
Filed 06/26
Traded 06/24
Eric VenkerPresident & Immunovant CEO
Sell10b5-1 planRoivant Sciences
Sell10b5-1 plan
Roivant Sciences
ROIV
$1.5M
46,234 sh
$1.5M
Filed 06/26
Traded 06/24

Eric Venker, CEO — plans to sell 611,079 sh of Roivant Sciences ROIV · $9.1M · around 09/23 | Whalegun